Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ligand Pharmaceuticals (LGND) Non Operating Investment Income (2017 - 2025)

Ligand Pharmaceuticals' Non Operating Investment Income history spans 9 years, with the latest figure at $22.1 million for Q4 2025.

  • For Q4 2025, Non Operating Investment Income rose 192.32% year-over-year to $22.1 million; the TTM value through Dec 2025 reached $18.4 million, down 75.43%, while the annual FY2025 figure was $18.4 million, 75.43% down from the prior year.
  • Non Operating Investment Income for Q4 2025 was $22.1 million at Ligand Pharmaceuticals, up from $7.8 million in the prior quarter.
  • Across five years, Non Operating Investment Income topped out at $110.8 million in Q1 2024 and bottomed at -$23.9 million in Q4 2024.
  • The 5-year median for Non Operating Investment Income is $1.4 million (2021), against an average of $8.2 million.
  • The largest annual shift saw Non Operating Investment Income crashed 6480.0% in 2021 before it surged 430.27% in 2022.
  • A 5-year view of Non Operating Investment Income shows it stood at -$13.4 million in 2021, then soared by 430.27% to $44.2 million in 2022, then crashed by 63.78% to $16.0 million in 2023, then plummeted by 249.14% to -$23.9 million in 2024, then soared by 192.32% to $22.1 million in 2025.
  • Per Business Quant, the three most recent readings for LGND's Non Operating Investment Income are $22.1 million (Q4 2025), $7.8 million (Q3 2025), and $939000.0 (Q2 2025).